How FDA, NIH, HHS & CDC Layoffs Are Impacting Industry: What the Regulatory Affairs Community is Saying
The regulatory affairs community is facing a new wave of uncertainty following recent layoffs at key federal agencies, including the FDA, NIH, HHS, and CDC. Last week, we surveyed regulatory affairs professionals across the pharmaceutical and biotech industries to assess the impact of these recent layoffs. Our goal was to understand how these changes are[…]